Profound Medical Corp. Share Price
NASDAQ: PROF | Micro CapProfound Medical Corp. Stock Performance
Open $7.22 | Prev. Close $8.00 | Circuit Range N/A |
Day Range $7.13 - $7.50 | Year Range $3.79 - $8.86 | Volume 2,384 |
Average Traded $7.30 |
Profound Medical Corp. Share Price Today
As of 10 August 2026, Profound Medical Corp.'s share price is $7.41. The stock opened at $7.22, compared to its previous close of $8.00. During today's trading session, Profound Medical Corp.'s share price traded between $7.13 and $7.50, with an average price of $7.31. Over the past 52 weeks, the stock has recorded a high of $8.86 and a low of $3.79. In terms of performance, Profound Medical Corp.'s share price has declined by 3.08% over the last six months and is up 64.92% on a year-on-year basis.
Profound Medical Corp. Share Price Chart
Profound Medical Corp. Stock Fundamentals & Key Indicators
Market Cap $223.88M | PE Ratio (TTM) 5.25 | Dividend Yield N/A |
EPS (TTM) $1.41 | Revenue (TTM) $16.10M | Return On Equity (TTM) -64.08% |
Profit Margin -264.44% | Debt to Equity 0.17 | Quarterly Earnings Growth YoY N/A |
Profound Medical Corp. Quarterly Profit & Loss
All figures in USD
Profound Medical Corp. Annual Profit & Loss
All figures in USD
About Profound Medical Corp.
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.
Profound Medical Corp. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $7.37 | $7.41 | +0.68% |
Jul 2026 | $6.75 | $7.36 | +10.68% |
Jun 2026 | $6.85 | $6.64 | -1.99% |
May 2026 | $6.81 | $6.78 | -0.37% |
Apr 2026 | $6.62 | $6.80 | +5.10% |
Mar 2026 | $7.49 | $6.47 | -15.25% |
Feb 2026 | $7.52 | $7.64 | +1.73% |
Jan 2026 | $7.82 | $7.51 | -5.00% |
Dec 2025 | $6.37 | $7.91 | +20.50% |
Nov 2025 | $6.05 | $6.56 | +8.25% |
Oct 2025 | $4.92 | $6.06 | +20.96% |
Sep 2025 | $4.46 | $5.01 | +11.58% |